Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

YCBD

cbdMD Inc

Feb 17 • 04:00PM ET

0.7764

+0.0752 10.72 %

Healthcare • Drug Manufacturers - Specialty & Generic • USA • AMEX

Today, 6:37 PMcbdMD reports Q1 FY2026 results with 12% sequential revenue growth and improved liquidity, marking a third straight sequential gain, and adds Bluebird to accelerate growth as its core business stabilizes.

Peers: TLRY ACB VFF TVRD OGI IIPR CRBP

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-3.92	Insider Own	14.85%	Shs Outstand	10.50M	Perf Week	-8.91%
Market Cap	8.15M	Forward P/E	-	EPS next Y	-0.09	Insider Trans	-26.10%	Shs Float	8.94M	Perf Month	-23.13%
Enterprise Value	6.67M	PEG	-	EPS next Q	-0.06	Inst Own	5.13%	Short Float	8.11%	Perf Quarter	5.20%
Income	-4.38M	P/S	0.42	EPS this Y	79.82%	Inst Trans	9.21%	Short Ratio	0.06	Perf Half Y	2.67%
Sales	19.19M	P/B	0.96	EPS next Y	59.09%	ROA	-19.44%	Short Interest	0.73M	Perf YTD	-42.49%
Book/sh	0.81	P/C	3.61	EPS next 5Y	-	ROE	-44.42%	52W High	4.50 -82.73%	Perf Year	-79.95%
Cash/sh	0.22	P/FCF	-	EPS past 3/5Y	86.54% -	ROIC	-60.55%	52W Low	0.47 65.16%	Perf 3Y	-99.24%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-18.46% -14.45%	Gross Margin	56.50%	Volatility	16.27% 15.39%	Perf 5Y	-99.95%
Dividend TTM	-	EV/Sales	0.35	EPS Y/Y TTM	80.17%	Oper. Margin	-11.27%	ATR (14)	0.14	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.13	Sales Y/Y TTM	-1.50%	Profit Margin	-22.80%	RSI (14)	43.48	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.05	EPS Q/Q	96.75%	SMA20	-6.73%	Beta	2.18	Target Price	2.00
Payout	-	Debt/Eq	0.11	Sales Q/Q	3.61%	SMA50	-25.61%	Rel Volume	0.14	Prev Close	0.70
Employees	42	LT Debt/Eq	0.00	Earnings	Feb 17 AMC	SMA200	-16.06%	Avg Volume	11.43M	Price	0.78
IPO	Nov 17, 2017	Option/Short	No / Yes	EPS/Sales Surpr.	4071.43% 0.40%	Trades		Volume	1,594,945	Change	10.72%

Today 04:10PM	cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026 (PR Newswire) +10.72%
Feb-12-26 05:31PM	cbdMD, Inc. to Host Conference Call to Discuss December 31, 2025 First Quarter Results (PR Newswire) -9.12%
Feb-02-26 09:00AM	cbdMD's Herbal Oasis Expands into Louisiana with Morales Beverage Group Following Strong Texas Momentum (PR Newswire) -16.42%
Jan-29-26 12:53PM	cbdMD Strengthens Regulatory Science Platform to Support Emerging Regulatory Cannabinoid Evaluation Pathways (PR Newswire)
Jan-14-26 09:00AM	cbdMD Announces Strategic Acquisition of Bluebird Botanicals (PR Newswire)
12:00AM	Loading…
Dec-20-25 12:00AM	cbdMD Inc (YCBD) Q4 2025 Earnings Call Highlights: Strategic Growth Amidst Regulatory Challenges (GuruFocus.com)
Dec-19-25 04:10PM	cbdMD Reports Third Consecutive Year of Operating Improvement, Strengthens Balance Sheet, and Regains NYSE American Continued Listing Compliance (PR Newswire) -21.76% -9.27%
03:01PM	cbdMD, Inc. Announces Closing of $2.25 Million Series C Preferred Stock Private Placement (PR Newswire)
Dec-17-25 07:16PM	cbdMD, Inc. to Host Conference Call to Discuss September 30, 2025, Fourth Quarter and Fiscal Year 2025 Results (PR Newswire) +58.74% -14.98%
Dec-08-25 11:08AM	cbdMD, Inc. Regains Compliance with NYSE American Listing Standards (PR Newswire)
Nov-21-25 08:30AM	cbdMD Reports Preliminary Unaudited Fourth Quarter and Fiscal 2025 Results (PR Newswire) -6.67%
Oct-22-25 10:03AM	cbdMD's Herbal Oasis Hemp-Derived THC-Infused Social Seltzer Brand Expands its Product Offerings (ACCESSWIRE) -5.66%
Oct-09-25 10:03AM	cbdMD's Herbal Oasis Expands its Florida Footprint with Bevtalk Distribution Partnership (PR Newswire)
Aug-15-25 03:21AM	cbdMD Inc (YCBD) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic Adjustments (GuruFocus.com) -10.98%
Aug-14-25 04:08PM	cbdMD Generates $4.6 Million of Revenue for the 3rd Quarter (Newsfile) -6.65%
10:22AM	Loading…
Aug-12-25 10:22AM	cbdMD, Inc. to Host Conference Call to Discuss June 30, 2025, Third Quarter of Fiscal Year 2025 Results (Newsfile)
Jun-24-25 07:00AM	cbdMD Expands Oasis Social Tonics to Total Wine (Newsfile) +6.15%
May-21-25 07:00AM	Herbal Oasis Expands Footprint with New Distribution Agreement in Georgia (Newsfile)
May-16-25 03:13AM	cbdMD Inc (YCBD) Q2 2025 Earnings Call Highlights: Strategic Moves and Financial Improvements ... (GuruFocus.com)
May-15-25 04:09PM	cbdMD Delivers Continued Revenue Growth and Trend Towards Profitability in Second Fiscal Quarter (Newsfile)
May-09-25 12:57PM	cbdMD, Inc. to Host Conference Call to Discuss March 31, 2025, Second Quarter of Fiscal Year 2025 Results (Newsfile) +8.72%
May-07-25 11:04AM	Herbal Oasis Expands Southeast Presence with New Distribution Agreement in North Carolina (Newsfile) -11.13%
Apr-24-25 07:00AM	Herbal Oasis Wins National Recognition at the 2025 High Spirits Awards (Newsfile) +6.29%
Apr-21-25 08:20PM	cbdMD, Inc. Announces Automatic Conversion Date of Series A Preferred Stock and One for Eight Reverse Split of its Common Stock Immediately Following the Automatic Conversion (Newsfile)
Apr-10-25 05:57PM	cbdMD, Inc. Announces Shareholder Approval of Automatic Conversion of Series A Preferred Stock and Other Results from Annual Meeting (Newsfile) -21.26%
Apr-08-25 11:19AM	Herbal Oasis Announces Distribution Agreement to Launch Statewide in Alabama and Select Florida Panhandle Markets (Newsfile) +10.00%
Apr-07-25 07:00AM	cbdMD Achieves Key Milestone in UK Novel Food Regulatory Approval (Newsfile)
Feb-14-25 02:20AM	cbdMD Inc (YCBD) Q1 2025 Earnings Call Highlights: Achieving Profitability and Debt-Free Status (GuruFocus.com) -15.09%
Feb-13-25 04:10PM	cbdMD Generates $5.1 Million in Revenue, Positive Earnings (Newsfile)
Feb-07-25 05:26PM	cbdMD, Inc. to Host Conference Call to Discuss December 31, 2024 First Quarter of Fiscal Year 2025 Results (Newsfile) -6.33%
10:30AM	Loading…
Jan-15-25 10:30AM	cbdMD Announces It Has Fully Satisfied Its Notes (Newsfile)
Jan-08-25 05:22PM	cbdMD Announces Additional Conversions of Its Convertible Notes (Newsfile) +13.28%
Jan-03-25 04:44PM	cbdMD, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standard (Newsfile) +39.49%
Dec-23-24 03:52PM	cbdMD Announces Company's CEO Joins the Board of Directors (Newsfile)
Dec-18-24 04:08PM	cbdMD Generates $19.1 Million in Year Over Year Reduction in Net Loss Improvement (Newsfile) -9.34% -7.04%
11:04AM	cbdMD, Inc. to Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results (Newsfile)
Dec-17-24 04:42PM	cbdMD, Inc. Reschedules Earnings Release and Conference Call (Newsfile) +29.12%
Dec-12-24 12:13PM	cbdMD, Inc. To Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results (Newsfile)
Nov-14-24 02:26PM	cbdMD Launches Herbal Oasis Social Tonics, Hemp-Derived THC Seltzers (Newsfile) +12.47%
Aug-26-24 04:25PM	cbdMD, Inc. Announces Acceptance of Compliance Plan by NYSE American (Newsfile)
Aug-14-24 04:10PM	cbdMD Delivers on Sequential Revenue Growth and Positive Net Income for Q3 2024 (Newsfile)
Aug-05-24 11:03AM	cbdMD, Inc. to Host Conference Call to Discuss Third Quarter of Fiscal 2024 Results (Newsfile) -5.12%
Jun-27-24 11:45AM	cbdMD Announces Publication of Human Clinical Trial Data (Newsfile) -5.31%
Jun-07-24 05:36PM	cbdMD, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards (Newsfile)
May-24-24 10:03AM	cbdMD Unveils ATRx Labs Premium Mushroom Line at GNC, Expanding cbdMD's Natural Wellness Solutions (Newsfile)
May-16-24 10:37AM	cbdMD Launches Max Chill Dragon Fruit D9 Gummies: Your Go-To Relaxation Blend for the Summer (Newsfile)
May-15-24 04:09PM	cbdMD Reports Second Quarter Results (Newsfile)
May-13-24 11:20AM	cbdMD, Inc. to Host Conference Call to Discuss Second Quarter of Fiscal 2024 Results (Newsfile)
Feb-13-24 04:10PM	cbdMD Reduces Year over Year Net Loss from Operations by $3.0 Million (Newsfile) -8.57%
Feb-08-24 04:05PM	cbdMD, Inc. to Host Conference Call to Discuss First Quarter of Fiscal 2024 Results (Newsfile)
10:10AM	cbdMD Welcomes Vice President of Wholesale Sales, Joe Baghadjian- Paving the Way for Future Growth (Newsfile)
Feb-02-24 05:00PM	cbdMD Announces Financing of $1,250,000 (Newsfile)
Jan-31-24 10:56AM	cbdMD Unveils THCV+CBG Energy Softgels, Ushering in a New Era of Wellness Solutions (Newsfile)
Jan-18-24 11:50AM	cbdMD Launches into Sprouts Farmers Market, Bringing Premium CBD Gummies to 175 Stores Nationwide (Newsfile) +6.36%
Dec-22-23 04:06PM	cbdMD Reduces Year over Year Net Loss from Operations by $55.8 Million (Newsfile) +5.17%
Dec-20-23 12:47PM	cbdMD, Inc. to Host Conference Call to Discuss September 30, 2023 Fourth Quarter and Fiscal Year 2023 Results (Newsfile)
Dec-14-23 11:03AM	cbdMD Wins Awards in Two Categories at Prestigious Best in Biz Awards (Newsfile)
Oct-25-23 05:50PM	cbdMD Announces Cancellation of Special Meeting (Newsfile)
Oct-05-23 09:00AM	cbdMD Announces Historic Partnership with FIFA-Affiliated Costa Rican Soccer Team (Newsfile) +5.33%
Sep-22-23 05:02PM	cbdMD Announces Adjournment of Special Meeting (Newsfile) -5.45%
09:58AM	Breaking Barriers: cbdMD's Research Validates Safe CBD Upper Dose (Newsfile)
Sep-14-23 12:48PM	Shareholders are Encouraged to Vote Well in Advance of the Proxy Deadline of 1:00 p.m. (Eastern time) on September 22, 2023 (Newsfile) +7.50%
Aug-25-23 09:00AM	Paw CBD Wins 2023 'Dog Hip & Joint Product of the Year' Pet Innovation Award (Newsfile)
Aug-22-23 08:30AM	cbdMD, Inc. Suspends Monthly Dividend Payment on Its Series A Cumulative Convertible Preferred Stock (Newsfile)
Aug-18-23 02:23PM	cbdMD Responds to Congressional Request for Information (RFI) on Regulation of CBD Products (Newsfile)
Aug-17-23 08:00AM	Paw CBD Recognized With Dog Hip & Joint Product Of The Year Award From Pet Innovation (GlobeNewswire)
Aug-10-23 04:48PM	cbdMD Demonstrates Strong Year-over-Year Performance, Significantly Reducing Net Loss by $30 Million (Newsfile)
Aug-07-23 10:00AM	cbdMD, Inc. to Host Conference Call to Discuss Third Quarter of Fiscal 2023 Results (Newsfile)
Aug-03-23 09:00AM	cbdMD Releases Tropical Hemp-derived THC + CBD Gummy Line to Elevate Consumer Wellness (Newsfile)
Jun-29-23 02:25PM	cbdMD Announces Migration to E-Commerce Platform, Shopify (Newsfile) +6.90%
Jun-22-23 09:00AM	cbdMD Announces Partnership with Medical Advisor, Dr. Lucille Vega (Newsfile)
May-15-23 04:10PM	cbdMD Stabilizes Revenue and Significantly Improves Operating Results (Newsfile) -6.65%
May-10-23 02:59PM	cbdMD, Inc. to Host Conference Call to Discuss Second Quarter of Fiscal 2023 Results (Newsfile)
May-03-23 02:02PM	cbdMD Announces Closing of $2.8 Million Underwritten Public Offering of Common Stock (Newsfile) -6.31%
Apr-30-23 08:51PM	cbdMD Announces Pricing of $2.8 Million Underwritten Public Offering of Common Stock (Newsfile)
Apr-28-23 04:49PM	cbdMD Announces Proposed Public Offering of Common Stock (Newsfile) -23.00% -40.55%
Apr-18-23 11:50AM	cbdMD's Clinical Study Supports Improved Mobility in Dogs (Newsfile)
Apr-14-23 04:05PM	cbdMD, Inc. Announces One-for-Forty Five Reverse Stock Split of Its Common Stock (Newsfile) -8.82%
Apr-12-23 11:57AM	cbdMD Expands its Reach to The United Kingdom with Launch on Amazon UK (Newsfile)
Mar-07-23 12:33PM	cbdMD Makes History Becoming the First CBD Brand to Achieve 3 NSFs Certified for Sport® Certifications (Business Wire) +9.94%
Feb-16-23 09:52AM	cbdMD to Present at NutraIngredients-USA's Sports and Active Nutrition Summit (Newsfile)
Feb-13-23 04:10PM	cbdMD Posts $15 Million in Net Income Improvement over Prior Year Quarter (Newsfile) -7.94%
11:24AM	cbdMD Receives $1 Million Return of Capital Following Closing of Adara SPAC Transaction (Newsfile)
Feb-06-23 04:05PM	cbdMD, Inc. to Host Conference Call to Discuss First Quarter of Fiscal 2023 Results (Newsfile)
Jan-26-23 04:47PM	cbdMD Maintains Commitment to Advocating for FDA Regulation Despite Recent News (Newsfile)
Jan-11-23 12:33PM	cbdMD Welcomes Shannon Charles as Chief Marketing Officer (Newsfile)
Dec-15-22 04:07PM	cbdMD Continues to Drive Operational Improvement (Newsfile) -21.83%
Dec-14-22 05:06PM	cbdMD, Inc. to Host Conference Call to Discuss Fourth Quarter and Fiscal 2022 Results (Newsfile) -12.48%
Nov-29-22 12:24PM	cbdMD Successfully Launches Into a Growing Japanese Market (Newsfile) +8.39%
Nov-17-22 11:03AM	cbdMD'S Human Clinical Study Demonstrates Strong Pain Benefits (Newsfile)
Oct-25-22 09:25AM	cbdMD to Present at ThinkEquity Conference on October 26, 2022, in New York City (Newsfile)
Oct-18-22 09:20AM	cbdMD Launches Powerful New Product Designed to Reduce Pain - cbdMD MAX (Newsfile) +7.06%
Oct-13-22 12:36PM	cbdMD Announces Strategic Launch of Strongest CBD at the Best Value (Newsfile)
Sep-28-22 09:15AM	cbdMD Launches Line of CBD Products with Wegmans Food Markets (Newsfile)
Aug-11-22 04:15PM	cbdMD Delivers on its Promise of Operating Improvement, adds Regulatory Depth to the Board (Newsfile) -6.43%
Aug-08-22 04:15PM	cbdMD, Inc. to Host Conference Call to Discuss June 30, 2022, Third Quarter Results (Newsfile) +11.76%
Aug-02-22 06:36PM	Former Charlotte CEO Marty Sumichrast denies SEC's fraud and self-dealing allegations (American City Business Journals) +6.50%
Jun-29-22 12:01PM	cbdMD's Dr. Sibyl Swift Provides Testimony To the FDA Science Board on Proper Safety Methods for CBD Products (Newsfile)
Jun-13-22 08:04PM	cbdMD CEO, board member Marty Sumichrast resigns with $590K severance following SEC lawsuit (American City Business Journals)
08:04AM	cbdMD, Inc. CEO Steps Down (Newsfile)

cbdMD, Inc. engages in the business of operating cannabidiol brands such as Paw cannabidiol and cbdMD botanicals. Its product categories include CBD tinctures, gummies, topical, and bath bombs. The company was founded on March 17, 2015 and is headquartered in Charlotte, NC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Crosnoe Clark R.	10% Owner	Dec 17 '25	Sale	2.32	550,701	1,276,842	17,875	Dec 19 09:16 AM
Clark R. Crosnoe, CRC Investme	Stockholder	Dec 17 '25	Proposed Sale	2.25	986,851	2,220,415		Dec 17 07:52 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

YCBD

cbdMD Inc

Upgrade your FINVIZ experience